IMA vs CLYM

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 14, 2026

IMA

38.5
AI Score
VS
CLYM Wins

CLYM

40.7
AI Score

Investment Advisor Scores

IMA

39score
Recommendation
SELL

CLYM

41score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric IMA CLYM Winner
Net Income -45.35M -41.79M CLYM
Operating Income -48.45M -47.46M CLYM
ROE -34.1% -18.3% CLYM
ROA -29.6% -17.7% CLYM
Total Assets 152.98M 236.56M CLYM
Cash 94.53M 39.73M IMA
Current Ratio 12.49 26.58 CLYM

Relative Price Performance (Last 90 Days)

IMA 1M: -13.9% · 3M: -37.8% CLYM 1M: -5.0% · 3M: -40.6%

Current Technical Phase

IMA

Markdown
Sell / avoid

Price below a falling SMA50 (slope -12.1%), weak momentum, RSI 26

RSI (14): 25.9 · Price: $3.47

CLYM

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 48

RSI (14): 47.6 · Price: $10.36

Fundamentals Snapshot

Metric IMA CLYM
Market Cap — —
Forward P/E -0.8 -10.4
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth 0.0% 0.0%
Gross Margin — —
Operating Margin 0.0% 0.0%
EPS -2.11 -0.81
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, CLYM is currently the stronger investment candidate, winning 6 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.